Atai Life Sciences: Positive BPL-003 Data In AUD Leads To Another Catalyst
Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.
H.C. Wainwright Keeps Their Buy Rating on ATAI Life Sciences (ATAI)
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on ATAI Life Sciences (ATAI – Research Report), with ...
Atai Life Sciences And 2 Other Promising Penny Stocks On US Exchanges
As the U.S. stock market navigates a week of fluctuating earnings reports and economic indicators, investors are keenly observing opportunities across various sectors. Penny stocks, often associated ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
BioSpace8d
Atai Touts Positive Data for Psychedelic Therapy in Alcohol Use Disorder
The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...
Best Penny Stocks to Watch in February 2025, Using Technical Analysis
These are some of the penny stocks with interesting charts using technical analysis that performed well over the past 30 days ...
Nasdaq27d
Atai Life Sciences Appoints Gerd Kochendoerfer As COO; Srinivas Rao Assumes Sole CEO Role
(RTTNews) - Biopharmaceutical company atai Life Sciences N.V. (ATAI) announced Friday key leadership appointments to advance its goal of delivering novel mental health therapeutics. Srinivas Rao ...
Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.
Shares of companies developing psychedelic treatments jumped while those of vaccine makers slipped after a Senate committee advanced the nomination of Robert F. Kennedy Jr. to lead the Health and ...